BSE filing, NSE: NCLIND. Summary written from the filing by ALFA Finder's alert engine.
NCL Industries Ltd: key numbers
- Share price
- ₹164.05
- Market cap
- ₹742.0 Cr
- Revenue (annual)
- ₹1,422 Cr
- Net profit (annual)
- ₹95.39 Cr
- P/E (TTM)
- 8.0×Sector 33.1×
- Promoter holding
- 42.49%+0.82% QoQ
- FII holding
- 3.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NCL Industries Ltd
All →NCL Industries Promoter Buying (Off-Market)
Promoter Charulata Goradia inherited 309,034 NCL shares (0.68%) on her husband's death. The exempt transmission leaves promoter group holding unchanged at 42.49%.
- Promoter stake change
- +0.68%
NCL Industries Other Announcement
NCL Industries discloses death of joint promoter Vinodrai V. Goradia. His 3,09,034 shares transfer to surviving joint holder Charulata V. Goradia with no change in aggregate promoter group holding.
NCL Industries Business Update
NCL Industries reported Q1 FY27 production of 781,056 MT cement, up 22% YoY. Hydro power fell 43% to 9.22 MU; no financial figures disclosed.
NCL Industries Other Announcement
NCL Industries Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
NCL Industries Promoter Buying: ₹0.12 Cr
Promoter and Director Kalidindi Ravi acquired 7,000 equity shares of NCL Industries Ltd from the open market for Rs.0.12 Crore.
- Value
- ₹0.12 Cr
- Promoter stake change
- +0.02%
NCL Industries Promoter Buying: ₹0.46 Cr
Promoters acquired 26,281 equity shares via market purchase. The transaction increases the aggregate promoter stake by approximately 0.07%.
- Value
- ₹0.46 Cr
- Promoter stake change
- +0.07%
Other board meeting date announcements
All →B.D. Industries (Pune) Board Meeting Date
B. D. Industries (Pune) will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-year results. The agenda items are proposed only and no decision has been taken yet.
Health X Platform Board Meeting Date
Health X Platform will hold a board meeting on 14 November 2026 to approve quarterly results. Trading window stays closed until 48 hours after declaration.
Exato Technologies Board Meeting Date
Board meeting set for November 14, 2026 to approve half-year results and an ESOP scheme. Trading window closed from October 1.
Astal Laboratories Board Meeting Date
Astal Laboratories will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the meeting.
Brainbees Solutions Board Meeting Date
Brainbees Solutions will hold a board meeting on November 14, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 16.
Senco Gold Board Meeting Date
Senco Gold schedules a board meeting on 13 November 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after declaration.